People and Markets

SRI League Tables
SRI Article Archive

Most Viewed: SRI / Green Bonds

Rubio is wrong to want to block Ant IPO
China’s sovereign bond: a missed SRI opportunity
Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
Deutsche adds to Apac ESG team
'China is a paper tiger,' says Kyle Bass, Hayman Capital Management

Already a subscriber?

Login

Try full access to GlobalCapital

Free trial

Want to learn more?

View subscription options

Latest Issue

1676, October 23, 2020

GlobalCapital will still be producing a weekly edition during the coronavirus pandemic. But we will not be printing it. Instead you can click on the link below to read the latest issue in your browser.

Digital Edition GlobalCapital Archive

Read the magazine on your mobile device

Download here for:

Apple
Android
Kindle

About us

About us
Contact us
Modern Slavery Act Transparency Statement

Connect with us

@GlobalCapNews
LinkedIn

Services

Advertise
Our partners
RSS
GlobalCapital Events
Events calendar
Social community

My Account

Renew
Subscribe
FAQ
Feedback
Terms and Conditions
Privacy Policy
Cookies

Quick links

All League Tables
Bank Profiles
Bond Comments
Deals & Deal Pipelines
Polls and Awards
GlobalCapital Archive
Special Reports Archive

People and Markets

Rubio is wrong to want to block Ant IPO

China’s sovereign bond: a missed SRI opportunity

Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO

Deutsche adds to Apac ESG team

'China is a paper tiger,' says Kyle Bass, Hayman Capital Management